-
13801por Gargiulo, Luigi, Pavia, Giulia, Valenti, Mario, Lleo de Nalda, Ana, Perugini, Chiara, Costanzo, Antonio, Narcisi, Alessandra“…RESULTS: Twenty patients had positive markers of hepatitis B virus (HBV) or hepatitis C virus (HCV). Seventeen patients had positive markers of HBV infection, and four patients had antibodies for HCV (one patient had serologic evidence of both infections). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13802por Nakabori, Tasuku, Abe, Yutaro, Higashi, Sena, Hirao, Takeru, Kawamoto, Yasuharu, Maeda, Shingo, Daiku, Kazuma, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Yamai, Takuo, Ikezawa, Kenji, Uehara, Hiroyuki, Ohkawa, Kazuyoshi“…The risk of exacerbating liver injury is of concern in patients infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), as immunotherapy can damage liver function because of the immune response against viral antigens. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13803por Nguyen, Hoang Bac, Le, Xuan-Thao Thi, Nguyen, Huy Huu, Vo, Thanh Thanh, Le, Minh Khoi, Nguyen, Ngan Trung, Do-Nguyen, Thien Minh, Truong-Nguyen, Cong Minh, Nguyen, Bang-Suong Thi“…The present study identified serum of 340 patients that were infected chronic hepatitis B virus or hepatitis C virus and divided in 2 groups including Hepatocellular carcinoma (HCC) and liver cirrhosis (LC) to measure their values of hTERT mRNA, AFP, AFP-L3%, and DCP, as well as combination of them. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13804“…Moreover, AKT1, PPARG, SRC, EGFR, CASP3, ESR1, and the other potential core targets might be involved in the treatment of T2DM by modulating the following pathways, containing insulin resistance, hepatitis C, pancreatic cancer, insulin signaling pathway, TNF signaling pathway, and PI3K-AKT signaling pathway. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13805por Gomes, Pollyanna Stephanie, Carneiro, Monique Pacheco Duarte, Machado, Patrícia de Almeida, de Andrade-Neto, Valter Viana, da Fonseca-Martins, Alessandra Marcia, Goundry, Amy, Pereira da Silva, João Vitor Marques, Gomes, Daniel Claudio Oliveira, Lima, Ana Paula Cabral de Araujo, Ennes-Vidal, Vítor, Sodero, Ana Carolina Rennó, De-Simone, Salvatore Giovanni, de Matos Guedes, Herbert L.“…The selected inhibitor, known as PF-429242, has already been used against the dengue virus, arenaviruses, and the hepatitis C virus. Moreover, it proved to have antilipogenic activity in a mouse model and caused hypolipidemia in human cells in vitro. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13806por Adeboyejo, Kazeem, Grosche, Victória Riquena, José, Diego Pandeló, Ferreira, Giulia Magalhães, Shimizu, Jacqueline Farinha, King, Barnabas J., Tarr, Alexander W., Soares, Márcia Maria Costa Nunes, Ball, Jonathan K., McClure, C. Patrick, Jardim, Ana Carolina Gomes“…Hepatitis C virus (HCV) is responsible for more than 180 million infections worldwide, and about 80 % of infections are reported in Low and Middle-income countries (LMICs). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13807por Mengistu, Dechasa Adare, Dirirsa, Gebisa, Mati, Elsai, Ayele, Dinku Mekbib, Bayu, Kefelegn, Deriba, Wegene, Alemu, Fekade Ketema, Demmu, Yohannes Mulugeta, Asefa, Yohanis Alemeshet, Geremew, Abraham“…BACKGROUND: Occupational exposure to blood and body fluids has become a serious public health problem for healthcare workers and is a major risk for the transmission of various infections such as human immune-deficiency virus, hepatitis B virus, and hepatitis C virus. This systematic review and meta-analysis aims to determine the career time and previous one-year global pooled prevalence of occupational exposure to blood and body fluids among healthcare workers. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13808por AlEid, Ahmad, Al Balkhi, Areej, Qutub, Adel, Abbarh, Shahem, AlLehibi, Abed, Almtawa, Abdullah, Al Otaibi, Nawwaf, AlGhamdi, Ahmed, AlGhamdi, Adel, Alamr, Abdulrahman, Ahmad, Shameem, Al Sayari, Khalid, Al Ibrahim, Bashaar, AlKhathlan, Abdullah“…BACKGROUND: Cost, adverse events, and long treatment duration can be significant obstacles in treating hepatitis C virus (HCV)-infected individuals. Shortening the treatment regimen can minimize these barriers, thereby enhancing adherence and increasing medication availability to more patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13809por Song, Yinjuan, Ge, Xin, Chen, Yulan, Hussain, Tariq, Liang, Zhengmin, Dong, Yuhui, Wang, Yuanzhi, Tang, Chengyuan, Zhou, Xiangmei“…Abbreviations: BMDM: mouse bone marrow-derived macrophage; BNIP3: BCL2/adenovirus E1B interacting protein 3; BNIP3L/NIX: BCL2/adenovirus E1B interacting protein 3-like; BCL2L13: BCL2-like 13 (apoptosis facilitator); CCCP: carbonyl cyanide m-cholorophenyl hydrazone; FUNDC1: FUN14 domain-containing 1; FKBP8: FKBP506 binding protein 8; HCV: hepatitis C virus; HBV: hepatitis B virus; IFN: interferon; L. monocytogenes: Listeria monocytogenes; M. bovis: Mycobacterium bovis; Mtb: Mycobacterium tuberculosis; Mdivi-1: mitochondrial division inhibitor 1; PINK1: PTEN-induced putative kinase 1; TBK1: TANK-binding kinase 1; TUFM: Tu translation elongation factor, mitochondrial; TEM: transmission electron microscopy…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13810por Stepanova, Maria, Kabbara, Khaled, Mohess, Denise, Verma, Manisha, Roche‐Green, Alva, AlQahtani, Saleh, Ong, Janus, Burra, Patrizia, Younossi, Zobair M.“…Common etiologies included nonalcoholic steatohepatitis (NASH; 31%), hepatitis C (23%), and alcoholic liver disease (18%); 30% also had hepatocellular carcinoma (HCC). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13811por Ghamari, Seyyed‐Hadi, Yoosefi, Moein, Abbasi‐Kangevari, Mohsen, Malekpour, Mohammad‐Reza, Saeedi Moghaddam, Sahar, Shahin, Sarvenaz, Esfahani, Zahra, Koolaji, Sogol, Shobeiri, Parnian, Ghaffari, Aydin, Sohrabi, Hanye, Kazemi, Ameneh, Rezaei, Negar, Larijani, Bagher, Farzadfar, Farshad“…Data of liver cancer and underlying causes, including hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, nonalcoholic steatohepatitis (NASH), and other causes were obtained from the Global Burden of Diseases 2019. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13812por Durand, Mélusine, Nagot, Nicolas, Michel, Laurent, Le, Sao Mai, Duong, Huong Thi, Vallo, Roselyne, Vizeneux, Amélie, Rapoud, Delphine, Giang, Hoang Thi, Quillet, Catherine, Thanh, Nham Thi Tuyet, Hai Oanh, Khuat Thi, Vinh, Vu Hai, Feelemyer, Jonathan, Vande Perre, Philippe, Minh, Khue Pham, Laureillard, Didier, Des Jarlais, Don, Molès, Jean-Pierre“…TL attrition was significantly associated with hepatitis C virus-infected PWIDs with MDE or PS (adjusted odds ratio [OR]: 0.53 [0.36; 0.80] and 0.59 [0.39; 0.88], respectively). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13813por Isken, Olaf, Walther, Thomas, Wong-Dilworth, Luis, Rehders, Dirk, Redecke, Lars, Tautz, Norbert“…Hepatitis C Virus NS2-NS3 cleavage is mediated by NS2 autoprotease (NS2(pro)) and this cleavage is important for genome replication and virus assembly. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13814por Riner, Andrea N., Girma, Selamawit, Vudatha, Vignesh, Mukhopadhyay, Nitai, Skoro, Nevena, Gal, Tamas S., Freudenberger, Devon C., Herremans, Kelly M., George, Thomas J., Trevino, Jose G.“…Using traditional criteria, Black patients were more likely to be ineligible for participation compared with White patients (42.4% v 33.2%, P = .023) secondary to hypoalbuminemia (14.1% v 7.9%, P = .023), HIV (3.1% v 0.3%, P = .010), hepatitis B (1.7% v 0%, P = .043), and hepatitis C (9.1% v 3.4%, P = .005). Black patients were also numerically more likely to be ineligible because of renal dysfunction, recent coronary stenting, and uncontrolled diabetes mellitus. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13815por Gane, Edward, de Ledinghen, Victor, Dylla, Douglas E., Rizzardini, Giuliano, Shiffman, Mitchell L., Barclay, Stephen T., Calleja, Jose Luis, Xue, Zhenyi, Burroughs, Margaret, Gutierrez, Julio A.“…Sustained virologic response at posttreatment Week 12 (SVR12) is the widely accepted efficacy endpoint for direct‐acting antiviral agents. Those with hepatitis C virus (HCV) are presenting younger with milder liver disease, potentially reducing need for long‐term liver posttreatment monitoring. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13816por Wong, William C. W., Marley, Gifty, Li, Jingjing, Yan, Weihui, Chan, Po-lin, Tucker, Joseph D., Tang, Weiming, Ni, Yuxin, Cheng, Dan Dan, Cong, Lou, Seto, Wai-Kay“…Despite the availability of hepatitis B virus (HBV) and hepatitis C virus (HCV) testing in primary care, testing rates in China remain low. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13817por Markby, Jessica, Gupta, Ekta, Soni, Divya, Sarin, Sanjay, Murya, Mugil, Katapur, Preetishirin, Tewatia, Navneet, Ramachandran, Babu Entoor, Ruiz, Ryan Jose, Gaeddert, Mary, Tyshkovskiy, Alexander, Adee, Madeline, Chhatwal, Jagpreet, Miglani, Sundeep, Easterbrook, Philippa, Sarin, Shiv K., Shilton, Sonjelle“…BACKGROUND AND AIMS: India has a significant burden of hepatitis C virus (HCV) infection and has committed to achieving national elimination by 2030. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13818por Shilton, Sonjelle, Markby, Jessica, Japaridze, Maia, Chihota, Violet, Shadaker, Shaun, Gvinjilia, Lia, Tsereteli, Maia, Alkhazashvili, Maia, Butsashvili, Maia, Stvilia, Ketevan, Ruiz, Ryan Jose, Asatiani, Alexander, Adamia, Ekaterine, Easterbrook, Philippa, Khonelidze, Irma, Gamkrelidze, Amiran“…BACKGROUND AND AIMS: In 2015, Georgia began a hepatitis C virus (HCV) elimination programme. Although screening programmes have been decentralized for high‐risk groups, viraemic testing remains a bottleneck for people who inject drugs. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13819por Ciancio, Alessia, Ribaldone, Davide Giuseppe, Salamone, Rossella, Bruno, Mauro, Caronna, Stefania, Debernardi Venon, Wilma, Giordanino, Chiara, Mondardini, Alessandra, Musso, Alessandro, Pennazio, Marco, Rolle, Emanuela, Sacco, Marco, Sprujevnik, Tatiana, De Angelis, Claudio, Saracco, Giorgio Maria“…BACKGROUND & AIMS: limited evidence is available to guide hepatologists regarding endoscopic surveillance of oesophageal varices (EV) in Hepatitis C Virus (HCV)‐positive cirrhotic patients achieving a sustained virologic response. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13820por Ayonrinde, Oyekoya T., Zelesco, Marilyn, Welman, Christopher J., Abbott, Steven, Adris, Niwansa“…Liver disorders were predominantly non‐alcoholic fatty liver disease (NAFLD), chronic hepatitis B (CHB), chronic hepatitis C (CHC) and alcohol‐related liver disease. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto